CVRdatabase
Menu

Solid Therapeutics ApS

Private limited companyCVR 43007068København NActive

Solid Therapeutics ApS is a private limited company, based in København N, active in research and experimental development on natural sciences and engineering, founded in 2022. Equity was negative at the end of 2025 (−DKK 15.4m). The company made a loss in both 2024 and 2025, most recently DKK 4.4m. 8 other companies in the database are registered at the same address.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profit−DKK 1.7m+59.9% vs. 2024
Net profit−DKK 4.4m+35.6% vs. 2024
Equity−DKK 15.4m−39.6% vs. 2024
Employees3latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • The loss got smaller: from DKK 6.8m to DKK 4.4m (2024 → 2025).

Employees

  • 3 fewer employees than a year earlier: 3 (07/2026) against 6 (07/2025).

Management and owners, last 24 months

  • New in management: John Sørensen Haurum (ceo, 28/08/2025).
  • Stepped down: Anne Mette Hyldgaard Trauelsen (ceo, 28/08/2025).

Registrations, last 24 months

  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2022–2025 · amounts in DKK thousand

Equity and net profit

−DKK 16m−DKK 14m−DKK 12m−DKK 10m−DKK 8m−DKK 6m−DKK 4m−DKK 2mDKK 02022202320242025
EquityNet profit
Financial figures for Solid Therapeutics ApS
2022202320242025Change
Revenuenot statednot statednot statednot stated–
Gross profit−398−2,739−4,214−1,688+59.9%
Operating profit (EBIT)−762−4,193−7,247−4,052+44.1%
Profit before tax−875−4,360−8,312−5,335+35.8%
Net profit−797−3,483−6,758−4,356+35.6%
Total assets3,57510,81311,0046,842−37.8%
Equity−757−4,240−10,998−15,354−39.6%
Liabilities4,33215,05322,00222,196+0.9%
Cash and cash equivalents3,4479,8308,9125,818−34.7%
Average number of employees1243−25%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 5m−DKK 4m−DKK 3m−DKK 2m−DKK 1mDKK 0DKK 1m2022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Negative equity

    Equity was −DKK 15.4m at the end of 2025.

    How is this calculated?

    Equity in the latest annual report is below zero.

  • Loss for 4 years in a row

    Net result has been negative in 2022–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

4 financial years
Annual reports for Solid Therapeutics ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202525/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202426/06/2025The companyPDFXBRL
202301/01/2023 – 31/12/202312/06/2024The companyPDFXBRL
202221/01/2022 – 31/12/202228/06/2023The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
012345608/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profit−DKK 1.7mNo. 342 of 421
Better than 19% of the companies in the industry
Equity−DKK 15.4mNo. 411 of 431
Better than 5% of the companies in the industry
Number of employees3No. 254 of 431
Better than 41% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bn
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 69,104of 69,742
Better than 1%
No. 69,725of 69,964
Better than 0%
Same industry and fewer than 20 employees329 companies in the comparison
No. 263of 323
Better than 19%
No. 319of 329
Better than 3%
Companies that are founded within the last five years16,675 companies in the comparison
No. 16,407of 16,627
Better than 1%
No. 16,630of 16,674
Better than 0%
All companies of type ApS66,508 companies in the comparison
No. 65,866of 66,379
Better than 1%
No. 66,268of 66,505
Better than 0%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Solid Therapeutics ApS−DKK 1.7m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Solid Therapeutics ApS−DKK 4.4m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Solid Therapeutics ApS−DKK 15.4m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Solid Therapeutics ApS3
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • John Sørensen Haurum10%
  • Receptor Holding ApS20%
  • Frimurer Holdings ApS20%
  • Haase Invest ApS10%
  • Stine Helene Falsig Petersen10%
  • Anne Mette Hyldgaard Trauelsen20%
  • Hagop Youssoufian10%
Solid Therapeutics ApS

Management

4 active registrations

Executive management

Executive management at Solid Therapeutics ApS
NameRoleAppointed
John Sørensen HaurumCEO28/08/2025

Board of directors

Board of directors at Solid Therapeutics ApS
NameRoleAppointed
John Sørensen HaurumChair of the board21/01/2022
Thue Walter SchwartzBoard member21/01/2022
Claus HaaseBoard member21/01/2022
Founders
John Sørensen Haurum, Thue Walter Schwartz, Thomas Michael Frimurer, Claus Haase, Stine Helene Falsig Petersen, Anne Mette Hyldgaard Trauelsen, Hagop Youssoufian
Former management (3)
Former management at Solid Therapeutics ApS
NameRoleAppointedResigned
Claus HaaseDirector21/01/202221/02/2022
John Sørensen HaurumDirector21/02/202201/02/2023
Anne Mette Hyldgaard TrauelsenCEO01/02/202328/08/2025

Signing rule: Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem eller af den samlede bestyrelse i forening.

Address and production units

1 active production units

Ole Maaløes Vej 3
2200 København N

København Municipality · Postcode 2200

Other companies at the address (8)

  • BII Holdings A/SOther financial service activities n.e.c.
  • Skape Bio ApSResearch and experimental development on natural sciences and engineering
  • Agrobiomics ApSResearch and experimental development on natural sciences and engineering
  • Tetrakit Technologies ApSResearch and experimental development on natural sciences and engineering
  • BioColor ApSResearch and experimental development on natural sciences and engineering
Production units
Production unitAddressEmployeesP number
Solid Therapeutics ApSOle Maaløes Vej 3, 2200 København N31027937930

Purpose

Selskabets formål er at udøve aktiviteter indenfor fund af lægemidler og udvikling heraf.

The purpose is quoted from the register in Danish.

Changes year by year

30 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
20254 changesmanagement 2 · accounts 1 · industry 1
  • John Sørensen Haurum appointed ceo
  • Anne Mette Hyldgaard Trauelsen stepped down as ceo
  • Annual report for 2024 published
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
20241 changeaccounts 1
  • Annual report for 2023 published
202310 changesaccounts 1 · name 1 · management 2 · ownership 6
  • Annual report for 2022 published
  • Name changed from Warburg Oncology ApS to Solid Therapeutics ApS
  • Anne Mette Hyldgaard Trauelsen appointed ceo
  • John Sørensen Haurum stepped down as director
  • Stine Helene Falsig Petersen registered as owner (10%)
  • Anne Mette Hyldgaard Trauelsen registered as owner (20%)
  • Hagop Youssoufian registered as owner (10%)
  • Stine Helene Falsig Petersen is no longer registered as owner
  • Anne Mette Hyldgaard Trauelsen is no longer registered as owner
  • Hagop Youssoufian is no longer registered as owner
202214 changesmanagement 6 · founded 1 · ownership 7
  • John Sørensen Haurum appointed director
  • Claus Haase stepped down as director
  • Registered as Warburg Oncology ApS
  • Claus Haase appointed board member
  • John Sørensen Haurum appointed chair of the board
  • Claus Haase appointed director
  • Thue Walter Schwartz appointed board member
  • John Sørensen Haurum registered as owner (10%)
  • Receptor Holding ApS registered as owner (20%)
  • Stine Helene Falsig Petersen registered as owner (20%)
  • Haase Invest ApS registered as owner (10%)
  • Frimurer Holdings ApS registered as owner (20%)
  • Anne Mette Hyldgaard Trauelsen registered as owner (5%)
  • Hagop Youssoufian registered as owner (5%)

Related companies

Same industry in København

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.

View in CVRReport a correction